Description
COMPOSITION: Each tablet contains Sorafenib 200 mg
INDICATION: SORAFEKAST is indicated for
- Hepatocellular cell carcinoma that cannot be removed by surgery (Liver cancer)
- Renal cell carcinoma (Kidney cancer)
- Difierentiated Thyroid carcinoma (Thyroid cancer)
PACKING: 30 Tablets Bottle & 120 Tablets Bottle